TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36 ILa | 0.00% |
|
+19.60% | +14.29% |
| Sales 2022 | 49.3 18.77K | Sales 2023 | 44.23 16.84K | Capitalization | 25.49M 9.7B |
|---|---|---|---|---|---|
| Net income 2022 | -48M -18.27B | Net income 2023 | -88M -33.5B | EV / Sales 2022 | 1,234,605 x |
| Net Debt 2022 | 17.5M 6.66B | Net Debt 2023 | 13.42M 5.11B | EV / Sales 2023 | 879,698 x |
| P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | 51 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.73% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | +19.60% | ||
| Current month | +25.44% | ||
| 1 month | +20.81% | ||
| 3 months | +5.57% | ||
| 6 months | +2.86% | ||
| Current year | +14.29% |
1 week
30.10
36.60
1 month
23.9036.60
Current year
23.0056.60
1 year
23.0056.60
3 years
23.00660.00
5 years
23.002 099.00
10 years
1.0011 300.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15-02-14 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 36 | 0.00% | 13,889 |
| 24-04-24 | 36 | +11.11% | 618,895 |
| 24-04-21 | 32.4 | +7.64% | 862,200 |
| 24-04-18 | 30.1 | +4.51% | 245,426 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 25, 2024 at 07:24 am EDT
More quotes
Tikun Olam Cannbit Pharmaceuticals Ltd, formerly Cannbit Pharmaceuticals Ltd, is an Israel-based company that produces medical cannabis. The Company engages in growing and cultivating medical cannabis products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +14.29% | 7.64M | |
| +23.05% | 3.66B | |
| +109.78% | 2B | |
| +87.30% | 61.69M |
- Stock Market
- Equities
- TKUN Stock
